Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome-Reference-Cited by-同舟云学术

Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome

Published:2019-01-14 Issue: Volume:2019 Page:1-15
ISSN:2314-8861
Container-title:Journal of Immunology Research
language:en
Short-container-title:Journal of Immunology Research

Author:

Cassius Charles¹²³⁴^ORCID,Le Buanec Hélène²³,Bouaziz Jean-David²³⁴,Amode Reyhan²³⁵

Affiliation:

1. Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

2. INSERM U976, Laboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, Hôpital Saint-Louis, Paris, France

3. Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France

4. Catholic University of Louvain, CHU UCL Namur, Yvoir, Belgium

5. Dermatology Department, Hôpital Bichat Claude Bernard, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

Abstract

Dermatomyositis pathophysiology is complex. In recent years, medical research has identified molecules associated with disease activity. Besides providing insights into the driving mechanisms of dermatomyositis, these findings could provide potential biomarkers. Activity markers can be used to monitor disease activity in clinical trials and may also be useful in daily practice. This article reviews molecules that could be used as biomarkers for diagnosis and monitoring dermatomyositis disease activity.

Publisher

Hindawi Limited

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://downloads.hindawi.com/journals/jir/2019/9141420.pdf

Reference135 articles.

1. Polymyositis and Dermatomyositis

2. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

3. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?

4. Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients

5. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune inflammatory myopathy biomarkers;Clinica Chimica Acta;2024-01

2. Malignancy in dermatomyositis: a mono-centric retrospective study of 134 patients in China and a potential predictive model;Frontiers in Medicine;2023-06-08

3. The association between clinical, subclinical features and autoantibody profile in Vietnamese dermatomyositis patients;PLOS Global Public Health;2023-01-12

4. Dermatomyositis: severe acute respiratory syndrome coronavirus 2, an initiator or a trigger?;Journal of the Egyptian Women's Dermatologic Society;2023

5. Skin manifestations and autoimmune disturbances in dermatomyositis;Translational Autoimmunity;2023